Appointment booking for Dr. Mohammed Memon, MD is currently not available.Dr. Mohammed Memon, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Mohammed Memon, MD (he/him) is a Oncologist in Huntley, IL with over 17 years of experience. What is your opinion of Dr. Mohammed Memon, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mohammed Memon, MD has received over $554 which includes payments from the following companies:
$126.62 from Genentech USA, Inc.
$59.75 from Merck Sharp & Dohme Corporation
$48.59 from E.R. Squibb & Sons, L.L.C.
$29.91 from Amgen Inc.
$28.15 from Pfizer Inc.
$25.70 from Janssen Biotech, Inc.
$21.40 from Celgene Corporation
$20.23 from HOLOGIC INC
$19.84 from GENZYME CORPORATION
$19.65 from TOLMAR Pharmaceuticals, Inc.
$17.32 from Jazz Pharmaceuticals Inc.
$15.76 from OPKO Pharmaceuticals, LLC
$15.44 from Exelixis Inc.
$15.16 from Janssen Pharmaceuticals, Inc
$14.82 from Taiho Oncology, Inc.
$14.29 from ProStrakan, Inc.
$13.80 from Takeda Pharmaceuticals U.S.A., Inc.
$12.86 from Novartis Pharmaceuticals Corporation
$12.49 from LILLY USA, LLC
$11.49 from Incyte Corporation
Payments received by Dr. Mohammed Memon, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!